K
    Krebs Biochemicals & Industries Ltd
    Pharmaceuticals 
₹ 69.07 -0.59 (-0.85%)
₹ 69.07 -0.59 (-0.85%)
- NSE
- BSE
Overview
- BSE Code 524518
- NSE Symbol KREBSBIO
- ISIN Demat INE268B01013
- Book Value (₹) -67.83
- Face Value (₹) 10.00
- Market Cap (₹ Cr.) 150.92
- P/E (TTM) 0.00
- EPS (TTM) 0.00
- Div Yield (%) 0.00
Performance
Today’s Low 69.04
Today’s High 70.50
52W Low 65.55
52W High 129.07
Open 69.64
Prev. Close 69.66
Volume 1,117.00
Corporate Actions
Krebs Biochemicals and Industries Limited - Trading Window
Sep 23, 2025Krebs Biochemicals and Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Krebs Biochemicals and Industries Limited - Certificate under SEBI (Depositories and Participants) Regulations, 2018
Apr 02, 2025The Company has enclosed herewith certificate received from RTA under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31.03.2025
Krebs Biochemicals and Industries Limited - Disclosure under SEBI Takeover Regulations
Apr 01, 2025Harish Kamath has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
About Krebs Biochemicals & Industries Ltd
Krebs Biochemicals & Industries Ltd[KBIL](Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same._x000D_
_x000D_
KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. _x000D_
_x000D_
KBIL since inception, has adopted global agenda for its growth by focusing on its specific area of expetise "Fermentation Technology". During 2001-02, the company has successfully launched Vitamin C(I P Grade) through Fermentation Process.The company has also received ISO 9002 Certification for Unit I at Nellore from Yarsley International Certifications Services accredited by United Kingdom Accreditation Services. The company is now producing and marketing Lovastatin,Simvastatin and Vitamin-C. _x000D_
_x000D_
The company is now in the process of installing a co-generation power plant at Unit-II. As a step in the direction of backward integration and to capitalise on co-generation and Ethanol manufacturing the company has successfully bidded and acquired the Nannapaneni Venkatrao Co-operative Sugars Ltd located at Jampani in Guntur District of Andhra Pradesh from the Andhra Pradesh Government in Dec 28, 2003._x000D_
| Founded | : 1991 | 
| Chairman | : R T Ravi | 
| Managing Director | : Jitendra Shah | 
| Address | : Kothapalli(V) Kasimkota(M), Anakapalli, Vishakapatnam, Andhra Pradesh, 531031, | 
| HO Tel | : 91-040-66808040 | 
Frequently Asked Questions
What is the price of Krebs Biochemicals & Industries Ltd share today? + 
How to buy stock of Krebs Biochemicals & Industries Ltd? + 
What is the 52 Week High and Low of Krebs Biochemicals & Industries Ltd? + 
What is the Market Cap of Krebs Biochemicals & Industries Ltd? + 
Open A Free Demat Account Today
Get StartedDocuments To Be Kept Handy
- PAN Card
- Cancelled Cheque
- Latest 6 month Bank Statement (Only for Derivatives Trading)



